zabofloxacin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibacterials, nalidixic acid derivatives | 5249 | 219680-11-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Zabofloxacin is a fluoroquinolone antibiotic with enhanced in-vitro activity against Streptococcus pneumoniae, including strains resistant to other antibiotics. The spectrum of activity of Zabofloxacin includes those bacterial strains that are responsible for most community-acquired respiratory infections.
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| March 20, 2015 | Korean Food and Drug Administration (KFDA) | Dong Wha Pharmaceuticals |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Acute infective exacerbation of chronic obstructive airways disease | indication | 285381006 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 6.27 | acidic |
| pKa2 | 8.46 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| LV66BA6V2G | UNII |
| 623574-00-5 | SECONDARY_CAS_RN |
| C2826065 | UMLSCUI |
| CHEMBL2107811 | ChEMBL_ID |
| 54556623 | PUBCHEM_CID |
| DB12479 | DRUGBANK_ID |
| CHEMBL232122 | ChEMBL_ID |
| 8594 | INN_ID |
| 10873 | IUPHAR_LIGAND_ID |
| C480202 | MESH_SUPPLEMENTAL_RECORD_UI |
Pharmaceutical products:
None